Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings.
MacMillan ML, Hippen KL, McKenna DH, Kadidlo D, Sumstad D, DeFor TE, Brunstein CG, Holtan SG, Miller JS, Warlick ED, Weisdorf DJ, Wagner JE, Blazar BR. MacMillan ML, et al. Among authors: holtan sg. Blood Adv. 2021 Mar 9;5(5):1425-1436. doi: 10.1182/bloodadvances.2020003219. Blood Adv. 2021. PMID: 33666654 Free PMC article. Clinical Trial.
The donor's dilemma.
Holtan SG, Weisdorf DJ. Holtan SG, et al. Blood. 2014 Jun 5;123(23):3538-9. doi: 10.1182/blood-2014-04-571661. Blood. 2014. PMID: 24904102 Free article. No abstract available.
A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality.
MacMillan ML, Robin M, Harris AC, DeFor TE, Martin PJ, Alousi A, Ho VT, Bolaños-Meade J, Ferrara JL, Jones R, Arora M, Blazar BR, Holtan SG, Jacobsohn D, Pasquini M, Socie G, Antin JH, Levine JE, Weisdorf DJ. MacMillan ML, et al. Among authors: holtan sg. Biol Blood Marrow Transplant. 2015 Apr;21(4):761-7. doi: 10.1016/j.bbmt.2015.01.001. Epub 2015 Jan 10. Biol Blood Marrow Transplant. 2015. PMID: 25585275 Free PMC article.
Monosomal karyotype at the time of diagnosis or transplantation predicts outcomes of allogeneic hematopoietic cell transplantation in myelodysplastic syndrome.
Ustun C, Trottier BJ, Sachs Z, DeFor TE, Shune L, Courville EL, Holtan SG, Dolan M, Weisdorf DJ, Warlick ED. Ustun C, et al. Among authors: holtan sg. Biol Blood Marrow Transplant. 2015 May;21(5):866-72. doi: 10.1016/j.bbmt.2015.01.017. Epub 2015 Jan 22. Biol Blood Marrow Transplant. 2015. PMID: 25620751 Free PMC article.
Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-versus-Host Disease in Reduced-Intensity Conditioning Double Umbilical Cord Blood Transplantation.
Bejanyan N, Rogosheske J, DeFor T, Lazaryan A, Esbaum K, Holtan S, Arora M, MacMillan ML, Weisdorf D, Jacobson P, Wagner J, Brunstein CG. Bejanyan N, et al. Biol Blood Marrow Transplant. 2015 May;21(5):926-33. doi: 10.1016/j.bbmt.2015.01.023. Epub 2015 Feb 3. Biol Blood Marrow Transplant. 2015. PMID: 25655791 Free PMC article. Clinical Trial.
Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802.
Holtan SG, Verneris MR, Schultz KR, Newell LF, Meyers G, He F, DeFor TE, Vercellotti GM, Slungaard A, MacMillan ML, Cooley SA, Blazar BR, Panoskaltsis-Mortari A, Weisdorf DJ. Holtan SG, et al. Biol Blood Marrow Transplant. 2015 Jun;21(6):1029-36. doi: 10.1016/j.bbmt.2015.02.018. Epub 2015 Mar 7. Biol Blood Marrow Transplant. 2015. PMID: 25759146 Free PMC article. Clinical Trial.
Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.
Lazaryan A, Weisdorf DJ, DeFor T, Brunstein CG, MacMillan ML, Bejanyan N, Holtan S, Blazar BR, Wagner JE, Arora M. Lazaryan A, et al. Biol Blood Marrow Transplant. 2016 Jan;22(1):134-40. doi: 10.1016/j.bbmt.2015.09.008. Epub 2015 Sep 11. Biol Blood Marrow Transplant. 2016. PMID: 26365153 Free PMC article.
172 results